Cornberg M - Search Results

1

S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11).

Cornberg M, Sandmann L, Protzer U, Niederau C, Tacke F, Berg T, Glebe D, Jilg W, Wedemeyer H, Wirth S, Höner Zu Siederdissen C, Lynen-Jansen P, van Leeuwen P, Petersen J; Collaborators:. Cornberg M, et al. Z Gastroenterol. 2021 Jul;59(7):691-776. doi: 10.1055/a-1498-2512. Epub 2021 Jul 12. Z Gastroenterol. 2021. PMID: 34255317 Free article. German. No abstract available.

2

Current and future treatment of hepatitis C.

Manns MP, Cornberg M, Wedemeyer H. Manns MP, et al. Among authors: cornberg m. Indian J Gastroenterol. 2001 Mar;20 Suppl 1:C47-51. Indian J Gastroenterol. 2001. PMID: 11293180 Review.

3

[PEG-interferons: significance for the treatment of viral hepatitis B and C].

Wedemeyer H, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. Dtsch Med Wochenschr. 2001 Jun 1;126 Suppl 1:S68-75. doi: 10.1055/s-2001-14495. Dtsch Med Wochenschr. 2001. PMID: 11450618 Review. German. No abstract available.

4

Treatment of acute hepatitis C with interferon alfa-2b.

Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP; German Acute Hepatitis C Therapy Group. Jaeckel E, et al. Among authors: cornberg m. N Engl J Med. 2001 Nov 15;345(20):1452-7. doi: 10.1056/NEJMoa011232. N Engl J Med. 2001. PMID: 11794193 Free article. Clinical Trial.

5

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Curr Gastroenterol Rep. 2002 Feb;4(1):23-30. doi: 10.1007/s11894-002-0034-y. Curr Gastroenterol Rep. 2002. PMID: 11825538 Review.

6

Hepatitis C: therapeutic perspectives.

Cornberg M, Wedemeyer H, Manns MP. Cornberg M, et al. Forum (Genova). 2001 Apr-Jun;11(2):154-62. Forum (Genova). 2001. PMID: 11948360 Review.

7

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

Cornberg M, Hinrichsen H, Teuber G, Berg T, Naumann U, Falkenberg C, Zeuzem S, Manns MP. Cornberg M, et al. J Hepatol. 2002 Dec;37(6):843-7. doi: 10.1016/s0168-8278(02)00300-8. J Hepatol. 2002. PMID: 12445427

8

Polyethylene glycol-interferon: current status in hepatitis C virus therapy.

Wedemeyer H, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S344-50. doi: 10.1046/j.1440-1746.17.s3.26.x. J Gastroenterol Hepatol. 2002. PMID: 12472962 Review.

9

[Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3].

Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP. Cornberg M, et al. Z Gastroenterol. 2003 Jun;41(6):517-22. doi: 10.1055/s-2003-39649. Z Gastroenterol. 2003. PMID: 12806536 German.

10

Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication.

Wedemeyer H, Cornberg M, Tegtmeyer B, Frank H, Tillmann HL, Manns MP. Wedemeyer H, et al. Among authors: cornberg m. Clin Microbiol Infect. 2004 Jan;10(1):70-2. doi: 10.1111/j.1469-0691.2004.00771.x. Clin Microbiol Infect. 2004. PMID: 14706089 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page